Premier Research Acquires Camargo Pharmaceutical Services
May 18, 2021
Premier Research, a global clinical research and development organization based in Morrisville, North Carolina, has acquired Camargo Pharmaceutical Services, a Cincinnati-based regulatory, strategy, and commercial consultancy for emerging biopharma. The acquisition expands Premier Research's product planning, development, and regulatory capabilities—strengthening services across oncology, pediatrics, rare disease, and accelerated approval pathways.
- Buyers
- Premier Research
- Targets
- Camargo Pharmaceutical Services
- Industry
- Healthcare Services
- Location
- Ohio, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Premier Biotech Acquires GH Solutions to Expand Point-of-Care Testing Presence
April 9, 2026
Healthcare Services
Align Capital Partners-backed Premier Biotech has acquired GH Solutions, a distributor of point-of-care diagnostic testing products. The deal expands Premier’s customer base and broadens the solutions GH can offer to Premier’s existing network, with focus on government and workplace customers.
-
Alcami Corporation Acquires Pacific Pharmaceutical Services
January 17, 2024
Healthcare Services
Alcami Corporation has completed the acquisition of Pacific Pharmaceutical Services, Inc. (PPS), a Reno-based cGMP pharmaceutical storage and clinical-support provider. The deal expands Alcami’s pharma storage and services footprint to the U.S. West Coast, enabling bicoastal coverage and enhanced support for pre-clinical and early clinical trial material management.
-
Pace Life Sciences Acquires Biopharma Global
September 8, 2022
Healthcare Services
Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.
-
Syner-G Acquires Impact Pharmaceutical Services
February 1, 2022
Healthcare Services
Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired Impact Pharmaceutical Services, a Research Triangle Park-based provider of medical writing, regulatory strategy, and regulatory publishing services for biotech and pharmaceutical clients. The deal, which closed in late December, expands Syner-G's CMC and regulatory capabilities to better support clients across pre-IND through post-marketing stages; financial terms were not disclosed.
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
ProPharma Group Acquires Diamond Pharma Services
March 2, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.